Wealth Enhancement Trust Services’s Kura Oncology KURA Stock Holding History

Wealth Enhancement Trust Services’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.31K	Buy	+211	New	+$1.99K	﹤0.01%	975

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $1.06B AUM 52.03% 1-Year Est. Return

HWAM

Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return

Wealth Enhancement Trust Services's KURA Position: Q2 2026 in Review

Wealth Enhancement Trust Services opened a new position in Kura Oncology (KURA) in Q2 2026: 211 shares worth $2.31K. The stake represents ﹤0.01% of the portfolio and ranks #975 among its holdings.

133 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

Wealth Enhancement Trust Services held 211 shares of Kura Oncology worth $2.31K as of Q2 2026.
Kura Oncology was a new Wealth Enhancement Trust Services position in Q2 2026.
Kura Oncology made up ﹤0.01% of Wealth Enhancement Trust Services's portfolio in Q2 2026, its #975 holding.
133 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Wealth Enhancement Trust Services's 13F filing for Q2 2026, filed 15 Jul 2026.